Search Results 11-20 of 15959 for SC

  1. Pasireotide s.c. in Patients with Post-Bariatric Hypoglycaemia - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of pasireotide s.c. on level 2 hypoglycaemic events after a mixed meal tolerance test (MMTT) in patients ...

  2. Katherine Butler, BAp(Sc)OT, AHT(BAHT) - Mayo Clinic Healthcare

    Katherine Butler, BAp(Sc)OT, AHT(BAHT), is a clinical specialist in hand therapy with 30-plus years of experience. She founded London Hand Therapy in 2006 ...

  3. David A. Krause, P.T., D.Sc. - Mayo Clinic Faculty Profiles

    Learn more about the research interests of David A. Krause, P.T., D.Sc., OCS.

  4. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to ...

  5. Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle - Mayo Clinic

    Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle · Overview · Participation eligibility · Participating Mayo Clinic locations.

  6. Kimberly G. Blumenthal, M.D., M.Sc. - Mayo Clinic Faculty Profiles

    Learn more about Kimberly G. Blumenthal, M.D., M.Sc.

  7. Matthew J. Maurer, Sc.D., M.S. - Mayo Clinic Faculty Profiles

    Matthew J. Maurer, Sc.D., M.S., a Mayo Clinic biostatistician, leads the Lymphoma Biostatistics and Data Science Lab. He focuses on clinical endpoints, ...

  8. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...

  9. Study of Sc-FOS for Pouchitis Prevention - Clinical Trials

    The main objective is to compare prebiotic therapy with placebo for the prevention of pouchitis after closure of diverting ileostomy in patients with an ileal ...

  10. A Study to Investigate the Effectiveness and Safety of Efgartigimod Ph20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy - Mayo Clinic

    The purpose of this study is to measure the treatment response from Efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory ...